Colorectal Cancer

 
Targeted Intervention Boosts Colorectal Cancer Screening Rates among US Adults
December 19, 2024

A centralized mailed FIT outreach intervention significantly improved CRC screening in a diverse patient population, according to recent data

January Issue of Patient Care Online Digital Edition is Now Live
December 16, 2024

Find details on US colorectal cancer screening rates, dietary interventions for people with IBS, and research on the primary drivers of cost of IBD care.

Preventing Colon Cancer Before It Starts: Researchers Explore Novel Therapeutic Strategies
December 06, 2024

William Grady, MD, talks about the latest research in colorectal cancer, including treatments targeting senescent cells that contribute to tumor formation.

Counseling Patients on False Positives in cfDNA Blood-Based Colorectal Cancer Screening
December 02, 2024

William Grady, MD, highlights ongoing efforts to improve test sensitivity and developments of new blood-based tests for early detection of CRC.

Colorectal Cancer Screening: Considerations for Using Cell-Free DNA Blood Tests in Older Adults
November 28, 2024

William Grady, MD, coauthor of the ECLIPSE study, discusses the use of non-invasive cfDNA blood-based tests for CRC screening in older adults.

Colorectal Cancer: How a New Blood-Based DNA Test Stacks Up in Screening Options
November 25, 2024

William Grady, MD, coauthor of the ECLIPSE trial, discusses how the Shield cfDNA blood-based test compares to traditional CRC screening methods.

Advantages of Blood-Based Colorectal Cancer Screening: An Expert Discussion
November 22, 2024

William Grady, MD, highlights the convenience and compliance of blood-based tests compared to colonoscopy and stool-based tests for colorectal cancer screening.

Sharp Rise in Early-Onset Colorectal Cancer Mortality Among Young US Adults: Daily Dose
November 21, 2024

Your daily dose of the clinical news you may have missed.

ECLIPSE Trial of Cell-Free DNA Blood-Based CRC Screening Test: Expert Overview
November 19, 2024

William Grady, MD, coauthor of the ECLIPSE clinical trial, discusses the study's rationale, methods, and key findings.

GLP-1RAs Cut Early Colorectal Cancer Risk in Adults with T2D: Daily Dose
November 14, 2024

Your daily dose of the clinical news you may have missed.